Formed in 2012, Precision Medicine Group is a specialized services company supporting next generation approaches to drug development and commercialization. Precision provides an integrated infrastructure that supports pharmaceutical and life sciences companies as they develop new products in the age of precision medicine. The company is headquartered in Bethesda, Maryland with offices throughout North America and Europe.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/23/17 | $275,000,000 |
Berkshire Partners J.H. Whitney Oak Investment Partners TPG | undisclosed |
